Publicacións (31) Publicacións de Xusto Fernández Fernández

2023

  1. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 42-53

2022

  1. Genotype-phenotype correlations in hypertrophic cardiomyopathy: a multicenter study in Portugal and Spain of the TPM1 p.Arg21Leu variant

    Revista Espanola de Cardiologia, Vol. 75, Núm. 3, pp. 242-250

2021

  1. Clinical utility of genetic testing in patients with dilated cardiomyopathy

    Medicina Clinica, Vol. 156, Núm. 10, pp. 485-495

  2. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

    ESC Heart Failure, Vol. 8, Núm. 1, pp. 95-105

  3. Prognostic value of reduced heart rate reserve during exercise in hypertrophic cardiomyopathy

    Journal of Clinical Medicine, Vol. 10, Núm. 7

2020

  1. Prognostic implications of pathogenic truncating variants in the TTN gene

    International Journal of Cardiology, Vol. 316, pp. 180-183

2016

  1. European cardiomyopathy pilot registry: EURObservational research programme of the European society of cardiology

    European Heart Journal, Vol. 37, Núm. 2, pp. 164-173

  2. Prognostic role of stress echocardiography in hypertrophic cardiomyopathy: The International Stress Echo Registry

    International Journal of Cardiology, Vol. 219, pp. 331-338

2015

  1. Exercise echocardiography and cardiac magnetic resonance imaging to predict outcome in patients with hypertrophic cardiomyopathy

    European Heart Journal Cardiovascular Imaging, Vol. 16, Núm. 4, pp. 423-432

  2. Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain

    Heart, Vol. 101, Núm. 13, pp. 1047-1053

2014

  1. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

    European Heart Journal, Vol. 35, Núm. 30, pp. 2010-2020

2012

  1. Prognostic value of exercise echocardiography in patients with hypertrophic cardiomyopathy

    Journal of the American Society of Echocardiography, Vol. 25, Núm. 2, pp. 182-189

2011

  1. Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy

    European Heart Journal, Vol. 32, Núm. 2, pp. 177-183

2010

  1. Disease: Cardiomyopathy, hypertrophic

    Human Genetics

  2. Disease: Cardiomyopathy, hypertrophic

    Human Genetics

  3. Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy

    BMC Medical Genetics, Vol. 11, Núm. 1

  4. Trastornos graves de la conducción cardiaca e implante de marcapasos en pacientes con miocardiopatía hipertrófica

    Revista Espanola de Cardiologia, Vol. 63, Núm. 8, pp. 985-988

2009

  1. Mutación en homocigosis en el gen MYBPC3 asociada a fenotipos severos y alto riesgo de muerte súbita en una familia con miocardiopatía hipertrófica

    Revista Espanola de Cardiologia, Vol. 62, Núm. 5, pp. 572-575

2008

  1. Reply

    Journal of the American College of Cardiology

  2. Sudden death in a patient with lamin A/C gene mutation and near normal left ventricular systolic function

    International Journal of Cardiology, Vol. 126, Núm. 1, pp. 136-137